Cargando…
Risk factor analysis of thymoma resection and its value in guiding clinical treatment
BACKGROUND: In this study, relationships between clinicopathologic characteristics and progression‐free survival (PFS) of patients after thymomectomy were analyzed to provide valuable suggestions regarding the treatment of thymoma. METHODS: Data from 187 thymoma patients undergoing surgery at Beijin...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315718/ https://www.ncbi.nlm.nih.gov/pubmed/37156630 http://dx.doi.org/10.1002/cam4.6043 |
_version_ | 1785067557120638976 |
---|---|
author | Du, Xin Cui, Jian Yu, Xin‐tao Yu, Lei |
author_facet | Du, Xin Cui, Jian Yu, Xin‐tao Yu, Lei |
author_sort | Du, Xin |
collection | PubMed |
description | BACKGROUND: In this study, relationships between clinicopathologic characteristics and progression‐free survival (PFS) of patients after thymomectomy were analyzed to provide valuable suggestions regarding the treatment of thymoma. METHODS: Data from 187 thymoma patients undergoing surgery at Beijing Tongren Hospital between January 1, 2006, and December 31, 2015, were retrospectively reviewed. We explored the risk factors for PFS among sex, age, thymoma‐associated MG, completeness of resection, histologic type and TNM stage, and investigated their interrelationship. RESULTS: Among the 187 patients, 18 patients (9.63%) had tumor recurrence/metastasis, and all of whom had in situ recurrence or pleural metastasis, and most of them (10 of 18 patients) had MG symptoms that reappeared or were aggravated. Fifteen patients (8.02%) died, and myasthenic crisis was a leading cause. Based on Cox regression analysis, only age (HR = 3.16; 95% CI: 1.44–6.91; p = 0.004) and the completeness of resection (HR = 9.03; 95% CI: 2.58–31.55; p = 0.001) were independent risk factors for PFS. Furthermore, we found that the completeness of resection was related to the histologic type (p = 0.009) and TNM stage (p < 0.001) by Fisher's exact test. CONCLUSIONS: The results of this cohort study remind us that we should pay attention to the reappearance or aggravation of MG after thymoma resection, because it is the leading cause of death and may indicate tumor progression. Furthermore, completeness of resection was related to the histologic type and TNM stage, but it was the independent risk factors of thymoma. Therefore, R0 resection is critical to the prognosis of thymoma. |
format | Online Article Text |
id | pubmed-10315718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103157182023-07-04 Risk factor analysis of thymoma resection and its value in guiding clinical treatment Du, Xin Cui, Jian Yu, Xin‐tao Yu, Lei Cancer Med RESEARCH ARTICLES BACKGROUND: In this study, relationships between clinicopathologic characteristics and progression‐free survival (PFS) of patients after thymomectomy were analyzed to provide valuable suggestions regarding the treatment of thymoma. METHODS: Data from 187 thymoma patients undergoing surgery at Beijing Tongren Hospital between January 1, 2006, and December 31, 2015, were retrospectively reviewed. We explored the risk factors for PFS among sex, age, thymoma‐associated MG, completeness of resection, histologic type and TNM stage, and investigated their interrelationship. RESULTS: Among the 187 patients, 18 patients (9.63%) had tumor recurrence/metastasis, and all of whom had in situ recurrence or pleural metastasis, and most of them (10 of 18 patients) had MG symptoms that reappeared or were aggravated. Fifteen patients (8.02%) died, and myasthenic crisis was a leading cause. Based on Cox regression analysis, only age (HR = 3.16; 95% CI: 1.44–6.91; p = 0.004) and the completeness of resection (HR = 9.03; 95% CI: 2.58–31.55; p = 0.001) were independent risk factors for PFS. Furthermore, we found that the completeness of resection was related to the histologic type (p = 0.009) and TNM stage (p < 0.001) by Fisher's exact test. CONCLUSIONS: The results of this cohort study remind us that we should pay attention to the reappearance or aggravation of MG after thymoma resection, because it is the leading cause of death and may indicate tumor progression. Furthermore, completeness of resection was related to the histologic type and TNM stage, but it was the independent risk factors of thymoma. Therefore, R0 resection is critical to the prognosis of thymoma. John Wiley and Sons Inc. 2023-05-08 /pmc/articles/PMC10315718/ /pubmed/37156630 http://dx.doi.org/10.1002/cam4.6043 Text en © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | RESEARCH ARTICLES Du, Xin Cui, Jian Yu, Xin‐tao Yu, Lei Risk factor analysis of thymoma resection and its value in guiding clinical treatment |
title | Risk factor analysis of thymoma resection and its value in guiding clinical treatment |
title_full | Risk factor analysis of thymoma resection and its value in guiding clinical treatment |
title_fullStr | Risk factor analysis of thymoma resection and its value in guiding clinical treatment |
title_full_unstemmed | Risk factor analysis of thymoma resection and its value in guiding clinical treatment |
title_short | Risk factor analysis of thymoma resection and its value in guiding clinical treatment |
title_sort | risk factor analysis of thymoma resection and its value in guiding clinical treatment |
topic | RESEARCH ARTICLES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315718/ https://www.ncbi.nlm.nih.gov/pubmed/37156630 http://dx.doi.org/10.1002/cam4.6043 |
work_keys_str_mv | AT duxin riskfactoranalysisofthymomaresectionanditsvalueinguidingclinicaltreatment AT cuijian riskfactoranalysisofthymomaresectionanditsvalueinguidingclinicaltreatment AT yuxintao riskfactoranalysisofthymomaresectionanditsvalueinguidingclinicaltreatment AT yulei riskfactoranalysisofthymomaresectionanditsvalueinguidingclinicaltreatment |